Search results
Radiotherapy with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy
Medical Xpress· 2 days agoOligoprogressive cancer occurs when cells from the original tumor travel within the body to fewer...
Hospital is first in WNY to offer noninvasive prostate cancer therapy
WGRZ-TV Buffalo· 13 hours agoPerformed noninvasively in the outpatient setting under general anesthesia, HIFU uses focal therapy...
Fusion Pharmaceuticals doses first subject in prostate cancer trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoFPI-2265 is an actinium-225-based prostate-specific membrane antigen (PSMA) targeting radioconjugate...
Ask Amy: I’m torn between sharing or keeping my Stage 4 cancer diagnosis
The Post-Standard· 13 hours agoLiving with – not dying of – cancer means a few lifestyle changes and the need to be more aware of...
MacroGenics reports progress in prostate cancer study By Investing.com
Investing.com· 1 day agoThe study investigates vobra duo, an antibody-drug conjugate (ADC), in patients with metastatic...
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena via Yahoo Finance· 5 days agoTumor Medical Affairs vice-president Luca Dezzani said: “Despitetreatment advancements over the last...
Everything we know about King Charles' cancer, from diagnosis to treatment
TODAY via Yahoo News· 2 days agoKing Charles III has just made his first public engagement at a London hospital since Buckingham...
NEWS CENTER Maine anchor Lee Goldberg marks milestone in prostate cancer journey with PSA about PSAs
WCSH 6 Portland· 2 days agoNEWS CENTER Maine's Lee Goldberg is a television veteran, having worked in the industry since 1991. This week marks three years since Lee had surgery to remove his prostate
...DO, FACOI, FACP is Lead Author of Case Study Demonstrating Importance of Genomic Testing in Early...
FOX 4 Kansas City· 3 days agoInherited genetic mutations are known to increase risk for many forms of cancer in women and men.
Immunic advances ‘potentially groundbreaking’ MS therapy vidofludimus calcium during Q1
Proactive Investors· 3 days agoImmunic Inc (NASDAQ:IMUX) continued to advance its clinical programs for its lead drug asset,...